66 related articles for article (PubMed ID: 38427104)
1. Chemical cyclization of tyrosine-containing peptides via in situ generated triazolinedione peptides.
Keyes ED; Mifflin MC; Austin MJ; Sandres J; Roberts AG
Methods Enzymol; 2024; 698():89-109. PubMed ID: 38886041
[TBL] [Abstract][Full Text] [Related]
2. Stapling of leu-enkephalin analogs with bifunctional reagents for prolonged analgesic activity.
Kijewska M; Wołczański G; Kosson P; Wieczorek R; Lisowski M; Stefanowicz P
Chem Commun (Camb); 2024 Mar; 60(22):3023-3026. PubMed ID: 38356394
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of β-Pyridyl α-Amino Acids: Conformationally Sensitive Charge Transfer-Based Fluorophores.
Riley LM; Marshall O; Harkiss AH; Senn HM; Sutherland A
Org Lett; 2024 Jun; ():. PubMed ID: 38865167
[TBL] [Abstract][Full Text] [Related]
4. Intramolecular backbone···backbone hydrogen bonds in polypeptide conformations. The other way around: ɛ-turn.
Toniolo C; Crisma M; Formaggio F; Alemán C; Ramakrishnan C; Kalmankar N; Balaram P
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27404945
[TBL] [Abstract][Full Text] [Related]
5. Applications of biaryl cyclization in the synthesis of cyclic enkephalin analogs with a highly restricted flexibility.
Różanowska M; Szczupaj G; Nowakowski M; Rajagopal P; Lipiński PFJ; Matalińska J; Misicka A; Lisowski M; Jaremko Ł; Jaremko M
Amino Acids; 2024 Mar; 56(1):18. PubMed ID: 38427104
[TBL] [Abstract][Full Text] [Related]
6. Use of NMR and fluorescence spectroscopy as well as theoretical conformational analysis in conformation-activity studies of cyclic enkephalin analogues.
Malicka J; Czaplewski C; Groth M; Wiczk W; Oldziej S; Lankiewicz L; Ciarkowski J; Liwo A
Curr Top Med Chem; 2004; 4(1):123-33. PubMed ID: 14754380
[TBL] [Abstract][Full Text] [Related]
7. Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3.
Malicka J; Groth M; Czaplewski C; Wiczk W; Liwo A
Biopolymers; 2002 Apr; 63(4):217-31. PubMed ID: 11807749
[TBL] [Abstract][Full Text] [Related]
8. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
9. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
Pletneva EV; Laederach AT; Fulton DB; Kostic NM
J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
[TBL] [Abstract][Full Text] [Related]
10. Biaryl-bridged macrocyclic peptides: conformational constraint via carbogenic fusion of natural amino acid side chains.
Meyer FM; Collins JC; Borin B; Bradow J; Liras S; Limberakis C; Mathiowetz AM; Philippe L; Price D; Song K; James K
J Org Chem; 2012 Apr; 77(7):3099-114. PubMed ID: 22352804
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
12. Peptide stapling by late-stage Suzuki-Miyaura cross-coupling.
Gruß H; Feiner RC; Mseya R; Schröder DC; Jewgiński M; Müller KM; Latajka R; Marion A; Sewald N
Beilstein J Org Chem; 2022; 18():1-12. PubMed ID: 35047078
[TBL] [Abstract][Full Text] [Related]
13. ECD exciton chirality method today: a modern tool for determining absolute configurations.
Pescitelli G
Chirality; 2022 Feb; 34(2):333-363. PubMed ID: 34791704
[TBL] [Abstract][Full Text] [Related]
14. Macrocyclization strategies for cyclic peptides and peptidomimetics.
Bechtler C; Lamers C
RSC Med Chem; 2021 Aug; 12(8):1325-1351. PubMed ID: 34447937
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
